Clinical Trial Update: An Open Label Comparing the Short Term Efficacy of Lacrisert [Phase 4]

View source ↗

Summary

An open-label Phase 4 trial comparing the short-term efficacy of Lacrisert for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• LACRISERT (hydroxypropyl cellulose)

Snippet

Sponsor: Virginia Eye Consultants | Conditions: Dry Eye | Phase 4 | Status: UNKNOWN